Basic Research TestroVax Tablets 2700 mg Perspective: Main

Basic Research TestroVax Tablets 2700 mg

90 ctUPC: 0085652800128
Purchase Options

A group of 43 men aged 27-37 years were divided into two groups: 1) the active Testosterone Booster compound group and 2) an indistinguishable placebo group. All subjects consumed their test product every morning at breakfast for 12 consecutive days, and blood samples were taken before treatment, after 6 and 12 days of treatment, and 3 days after stopping treatment. All blood samples were drawn between 9:30-10:30 am, a time of day when serum oscillations of testosterone are at their minimum. Results showed that serum testosterone levels in the active group were significantly increased compared to those of the placebo group over the course of the study, wherein the active TestosteroneBooster compound led to a 42% increase in testosterone after 12 days of use. Interestingly, 3 days after the suspension of treatment, testosterone was still increase 1.22 fold compared to baseline in the treatment group, showing a lasting effect.